Gen Yamada

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Scientific Reports.

Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Journal of Nephrology.

Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study

S. Ito, Hiroshi Sato, Toshinobu Sato, 2016, Clinical and Experimental Nephrology.

Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study

S. Ito, M. Satoh, Hiroshi Sato, 2018, Clinical and Experimental Nephrology.

Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma

S. Ito, H. Harigae, Hiroshi Sato, 2018, CEN Case Reports.

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study

S. Ito, Hiroshi Sato, M. Nakayama, 2021, PloS one.

Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study

Mina Kato, Tsutomu Inoue, S. Goto, 2023, Clinical and Experimental Nephrology.

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR.

M. Landray, F. Kronenberg, B. Brenner, 2018 .